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A B S T R A C T
Background: Factors inﬂuencing dissociated pulmonary vein (PV) potentials (DPVPs) in atrial ﬁbrillation
(AF) patients undergoing circumferential PV isolation have not been investigated. Furthermore, the
clinical implications of such DPVPs remain controversial.
Methods: Circumferential PV isolation as a ﬁrst ablation procedure was performed in 688 consecutive
patients with AF (460 men; mean age, 58.9  10.5 years). The clinical implications of and factors
inﬂuencing DPVPs were evaluated.
Results: Acute PV isolation was achieved in 679 (98.7%) patients. A total of 578 (42.6%) ipsilateral PVs
with DPVPs were documented in 378 (55.7%) patients (DPVPs group). Multivariate analysis revealed that
male gender [odds ratio (OR): 1.894; 95% conﬁdence interval (CI): 1.344–2.667; p < 0.001] and
paroxysmal AF (OR: 1.715; 95% CI: 1.182–2.488; p = 0.005) were independent factors for DPVPs. The
incidence of acute and intraoperative PV reconnection (PVR) was higher in the DPVPs group than in the
non-DPVPs group (33.1% vs. 17.9%; p < 0.001 and 44.4% vs. 28.2%; p < 0.001). After the ﬁrst procedure,
244 (65.6%) DPVPs-group patients and 168 (56.4%; p = 0.015) non-DPVPs group patients were free from
AF recurrence. During repeat procedures, PVR incidence was similar in the DPVPs group (81.8%) and non-
DPVPs groups (83.3%; p = 0.863).
Conclusion: Male gender and paroxysmal AF were independent risk factors for DPVPs in patients
undergoing circumferential PV isolation. DPVPs had a signiﬁcant impact on acute and intraoperative
PVR. The outcomes of the ﬁrst ablation procedure were better in patients with DPVPs.
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Electrical isolation of the pulmonary veins (PVs) has been
considered the cornerstone of catheter ablation for the treatment
of atrial ﬁbrillation (AF) [1–4]. Dissociated PV potentials (DPVPs)
of a primarily slow and repetitive nature within the PVs, a
demonstration of PV exit block and entrance block, are accepted as
a sign of electrical disconnection of the PVs from the left atrium
(LA) during PV isolation [5,6]. The incidence of DPVPs during PV
isolation ranges from 9% following segmental isolation to 40%
following antral isolation [5,7]. Studies have suggested that PVs* Corresponding author at: Department of Cardiology, Shanghai First People’s
Hospital, Shanghai Jiao Tong University, No 100, Haining Road, Shanghai 200080,
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0914-5087/ 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rightswith DPVPs, or arrhythmogenic PVs, are more likely to have an
extensive connection with the LA and be associated with early AF
recurrence [8–10]. However, apart from the type of procedure,
factors that inﬂuence the occurrence of DPVPs have not been
investigated. Furthermore, the impact of such DPVPs on PV
reconnection (PVR) remains controversial and has not been
systematically assessed in a large sample. Therefore, in this study,
we identiﬁed the factors that inﬂuence the occurrence of DPVPs
and evaluated the clinical implications of such DPVPs in AF
patients who underwent circumferential PV isolation as a ﬁrst
ablation procedure.
Methods
Study population
The study population consisted of 688 consecutive patients
(460 men; mean age, 58.9  10.5 years) with paroxysmal or reserved.
Fig. 1. Identiﬁcation of spontaneous activities (dissociated pulmonary vein
potentials; DPVPs). Tracings were obtained using surface electrocardiographic
(ECG) leads I, aVF, V1. Intracardiac electrograms were recorded using a coronary
sinus catheter (CS1,2 to CS9,10), a Lasso catheter within the right superior
pulmonary vein (RSPV1,2 to RSPV10,1), and the distal pair electrodes of an ablation
catheter (ABL). DPVPs were deﬁned as sharp and high-frequency potentials that
were not associated with far-ﬁeld atrial potentials or catheter manipulation. Panel
A: Repetitive DPVPs ($) from the RSPV were recorded after circumferential
pulmonary vein isolation in a patient. Panel B: Sustained ﬁbrillatory activities were
documented from the RSPV after circumferential pulmonary vein isolation in
another patient.
Fig. 2. Illustration of pulmonary vein (PV) reconnection in a patient with
spontaneous activities (dissociated pulmonary vein potentials; DPVPs) in the
PVs. Tracings were obtained using surface electrocardiographic leads I, aVF, V1.
Intracardiac electrograms were recorded using a coronary sinus catheter (CS1,2 to
CS9,10), a Lasso catheter within the left superior PV (LSPV1,2 to LSPV10,1) and the
distal pair of electrodes of an ablation catheter (ABL). Repetitive DPVPs ($) were
recorded from the LSPV after circumferential PV isolation in a patient. Interestingly,
during the 30-min observation period, PV reconnection with the left atrium (LA)
was documented as PV potentials (") conducted from the LA. Note that the
activation sequence of the DPVPs was different from that of the PV potentials
conducted from the LA.
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who were scheduled to undergo their ﬁrst ablation procedure
between February 2007 and January 2011. Paroxysmal and persistent
AF were deﬁned according to the expert consensus statement
[4]. Written informed consent was obtained from every patient.
Preoperative preparation and ablation procedure
The preoperative preparation has previously been described in
detail [11,12]. The ablation procedure was performed while
patients were under sedation with a bolus of midazolam and
analgesia with a continuous infusion of fentanyl [11].
The protocol of AF ablation has previously been described in
detail [11,12]. A multipolar electrode 6F catheter was positioned in
the coronary sinus (CS). A transseptal puncture was performed,
and two long sheaths were placed in the LA. Electroanatomical
mapping and ablation were performed with a 3.5-mm-tip catheter
(ThermoCool Navi-Star, Biosense Webster, Diamond Bar, CA, USA).
Image integration with the reconstructed computed tomography
scan was performed. Circumferential PV isolation was performed
just outside the ostia of the ipsilateral PVs. A circular mapping
catheter (Lasso, Biosense Webster) was placed within the superior
or inferior PV or within the branches of a common PV to identify
the breakthrough region of the LA to PV conduction and to guide
gap ablation for PV isolation. If AF persisted, linear ablation and
complex fractionated atrial electrogram ablation were performed
if necessary. Electrical or drug cardioversion was attempted to
restore sinus rhythm when AF termination could not be achieved
with the abovementioned steps. After cardioversion, bidirectional
conduction block of all the ablation lines was checked, and
reinforcement ablation was performed, if necessary, to conﬁrm the
bidirectional conduction block.
Irrigated radiofrequency energy was delivered with an upper
temperature limit of 43 8C, a maximum radiofrequency power of
38 W and an infusion rate of 17–25 ml/min. In all patients, the
maximal power delivered to the superior vena cava and the CS was
set at 25 W, to minimize the risk of cardiac tamponade or phrenic
nerve impairment. The maximal power delivered to the posterior
wall was set at 35 W, to minimize the risk of esophageal injury.
Identiﬁcation and evaluation of DPVPs and PVR
Immediately after the ipsilateral PVs were isolated, the
electrical activities in the isolated veins were assessed by placing
the Lasso catheter within each PV of the ipsilateral PVs for 5 min in
each PV. After placement and stabilization of the Lasso catheter,
the 5-min recording period was started, and the Lasso catheter was
not moved during this period. DPVPs were deﬁned as sharp and
high-frequency potentials that were not associated with the far-
ﬁeld atrial potentials or with manipulation of the catheters (Fig. 1).
For paroxysmal AF, isoproterenol was used to detect DPVPs after
PV isolation during the initial procedure. Patients with DPVPs were
assigned to the DPVPs group and those without such DPVPs were
assigned to the non-DPVPs group.
After the recording period, the Lasso catheter was placed within
the PVs (in the PVs with more frequent DPVPs if more than one
ipsilateral vein had DPVPs, or in the superior PV if no DPVPs were
documented in the ipsilateral PVs) for at least 30 min (including
the 5 min observation period for each PV in the ipsilateral PVs) to
evaluate and document the DPVPs and PVR (Fig. 2). Acute PVR was
deﬁned as re-conduction with the LA within 30 min after isolation.
Intraoperative PVR was deﬁned as PVR occurring during the
ablation procedure, including acute PVR. The timing of PVR was
also documented.
For those patients who underwent a repeat procedure for
recurrent atrial arrhythmias, the presence or absence of DPVPs was
Table 1
Comparison between the DPVPs group and the non-DPVPs group.
Factors DPVPs group
N = 378
Non-DPVPs group
N = 301
p-value
Male, n (%) 276 (73.0) 179 (59.5) <0.001
Age, years 58.4  10.6 59.4  10.5 0.200
Type of AF
Paroxysmal, n (%) 261 (69.0) 169 (56.1) 0.001
Non-paroxysmal, n (%) 117 (30.9) 132 (43.9) 0.001
History of AF, months 74.5  74.0 75.1  75.5 0.923
Body mass index, kg/m2 24.7  2.9 24.7  3.0 0.978
Body surface area, m2 1.78  0.17 1.77  0.19 0.350
Left atrium diameter, mm 41.5  5.5 42.8  6.5 0.006
Left ventricular ejection
fraction, %
64.3  5.5 64.0  6.5 0.606
Comorbidities, n (%) 197 (52.1) 172 (57.1) 0.191
Hypertension, n (%) 184 (48.7) 152 (50.5) 0.637
Coronary heart disease,
n (%)
9 (2.4) 4 (1.3) 0.320
Diabetes mellitus, n (%) 34 (9.0) 27 (9.0) 0.991
Cardiomyopathy, n (%) 4 (1.1) 7 (2.3) 0.230
Rheumatic heart disease,
n (%)
2 (0.5) 14 (4.6) <0.001
History of cerebral embolism,
n (%)
20 (5.3) 18 (6.0) 0.698
History of cardiac surgery,
n (%)
2 (0.5) 15 (5.0) <0.001
Preoperative amiodarone,
n (%)
73 (19.3) 80 (26.6) 0.024
Beta-receptor blocker, n (%) 135 (35.7) 113 (37.5) 0.623
Calcium channel blocker,
n (%)
47 (12.4) 37 (12.3) 0.956
AF, atrial ﬁbrillation; DPVPs, dissociated pulmonary vein potentials.
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for detecting DPVPs and inducing atrial arrhythmia after the PV
isolation. Chronic PVR was deﬁned as PVR with the LA at the
beginning of the repeat procedure.
Follow-up
After the procedure, all patients were asked to participate in
periodic follow-up in an outpatient clinic and via telephone
interviews. The presence/absence of AF was evaluated on the basis
of their symptoms, electrocardiographic recordings, and 24-h
ambulatory monitoring. Freedom from AF recurrence was deﬁned
as no AF (symptomatic and asymptomatic AF episodes) or
arrhythmia recurrence (including atrial tachycardia and atrial
ﬂutter) lasting less than 30 s in patients not receiving antiarrhyth-
mic drugs, after a blanking period of 3 months. The protocol of
follow-up has previously been described in detail [11,12].
Statistical analysis
Continuous variables are expressed as mean and standard
deviation. Discrete variables are presented as percentages.
Baseline characteristics of the patients were compared between
the two groups to determine the factors inﬂuencing DPVPs. An
independent samples t-test was performed to evaluate between-
group differences in continuous variables, while the Fisher exact
test or x2 test was used for categorical variables. Logistic regression
analysis was performed to identify independent risk factors for
DPVPs. All tests were two-tailed. A p-value of <0.05 was
considered statistically signiﬁcant. Statistical analyses were
performed using the SPSS 17.0 software package (SPSS Inc.,
Chicago, IL, USA).
Results
Ablation results and complications
Circumferential PV isolation was performed successfully in
679 patients. In the remaining nine patients, one ipsilateral PV
continued to have signiﬁcantly delayed PV potentials. Thus, the
acute success rate of PV isolation was 98.7%.
In the study population, a total of 38 (5.6%) complications were
encountered. There were 15 vascular access-related complications
(10 femoral hematomas, 3 femoral arterio-venous ﬁstulas and
2 femoral pseudo-aneurysms), which were managed conserva-
tively. In addition, there occurred one pneumothorax and three
cerebral infarctions, which were also managed conservatively,
without any sequelae. Moreover, there were 10 pericardial
effusions (all managed conservatively without any sequelae)
and 9 pericardial tamponades (resolved by pericardiopuncture
in ﬁve patients and by surgical drainage in four patients). There
were no other major complications.
Incidences and inﬂuence factors of DPVPs
DPVPs were documented in 578 of 1358 ipsilateral PVs (42.6%;
294 left PVs and 284 right PVs) in 378 of the 679 patients (55.7%;
200 with both sides; DPVPs group). The incidence of DPVPs did not
signiﬁcantly differ between patients with DPVPs in the left PVs and
those with DPVPs in the right PVs (43.3% vs. 41.8%; p = 0.583). In
our study, DPVPs were classiﬁed into two types: ectopic rhythm
(regular or irregular) and ﬁbrillatory activities. Fibrillatory
activities were documented in 35 of 578 ipsilateral PVs (6.1%;
21 left PVs and 14 right PVs) in 32 of 378 patients (8.5%; 3 with
both sides). The incidence of ﬁbrillatory activities was similar in
the left and right PVs (7.1% vs. 4.9%; p = 0.265).Comparisons between the DPVPs and non-DPVPs groups are
shown in Table 1. Univariate analysis revealed that gender
(p < 0.001), rheumatic heart disease (RHD; p < 0.001), history of
cardiac surgery (p < 0.001), type of AF (p = 0.001), LA diameter
(p = 0.006), and preoperative amiodarone therapy (p = 0.024)
signiﬁcantly differed between the DPVPs and non-DPVPs groups.
Multivariate analysis revealed that male gender [odds ratio (OR):
1.894; 95% conﬁdence interval (CI): 1.344–2.667; p < 0.001] and
paroxysmal AF (OR: 1.715; 95% CI: 1.182–2.488; p = 0.005) were
independently associated with the presence of DPVPs.
Interestingly, age (p < 0.001), comorbidities (p = 0.002; espe-
cially RHD and diabetes mellitus), history of cardiac surgery
(p = 0.001) and type of AF (p = 0.004) signiﬁcantly differed between
male and female patients (Table 2).
Incidence of acute and intraoperative PVR
During the 30-min observation and evaluation period, acute
PVR occurred in 205 of 1358 ipsilateral PVs (15.1%; 110 left PVs and
95 right PVs) in 179 of 679 patients (26.4%), at a mean of
17.1  9.6 min after isolation. After this 30-min period, PVR was
observed in an additional 97 ipsilateral PVs (7.1%; 46 left PVs and
51 right PVs) in 74 patients (10.9%), at a mean of 54.8  30.8 min after
isolation. Thus, intraoperative PVR was observed in 302 ipsilateral
PVs (22.2%; 156 left PVs and 146 right PVs) in 253 patients (37.3%), at
25.6  23.1 min after isolation.
The incidence of acute and intraoperative PVRs was higher in
the DPVPs group than in the non-DPVPs group (33.1% vs. 17.9%;
p < 0.001 and 44.4% vs. 28.2%; p < 0.001, respectively; Table 3).
However, the timing of acute and intraoperative PVRs did not
signiﬁcantly differ between the two groups (Table 3). The
incidence of acute and intraoperative PVR was similar in the left
and right PVs (acute PVR: 16.2% vs. 14.0%; p = 0.256; intraoperative
PVR: 23.0% vs. 21.5%; p = 0.514). Moreover, the incidence of acute
and intraoperative PVRs was similar in DPVPs present with
Table 2
Comparisons between male and female patients.
Factors Male
N = 455
Female
N = 224
p-value
Age, years 57.6  10.6 61.5  10.0 <0.001
Type of AF
Paroxysmal, n (%) 271 (59.6) 159 (71.0) 0.004
Non-paroxysmal, n (%) 184 (40.4) 65 (29.0) 0.004
History of AF, months 75.5  78.3 73.2  66.4 0.708
Body mass index, kg/m2 25.0  2.9 24.1  3.1 0.001
Body surface area, m2 1.85  0.14 1.61  0.13 <0.001
Left atrium diameter, mm 42.2  6.0 41.9  6.0 0.592
Left ventricular ejection
fraction, %
64.0  6.0 64.5  6.1 0.279
Comorbidities, n (%) 228 (50.1) 141 (62.9) 0.002
Hypertension, n (%) 216 (47.5) 120 (53.6) 0.135
Coronary heart disease, n (%) 8 (1.8) 5 (2.2) 0.767
Diabetes mellitus, n (%) 28 (6.1) 33 (14.7) <0.001
Cardiomyopathy, n (%) 7 (1.5) 4 (1.8) 0.758
Rheumatic heart disease, n (%) 3 (0.7) 13 (5.8) <0.001
History of cerebral embolism,
n (%)
22 (4.8) 16 (7.1) 0.219
History of cardiac surgery, n (%) 5 (1.1) 12 (5.4) 0.001
Preoperative amiodarone, n (%) 108 (23.7) 45 (20.1) 0.285
Beta-receptor blocker, n (%) 157 (34.5) 91 (40.6) 0.119
Calcium channel blocker, n (%) 55 (12.1) 29 (12.9) 0.749
AF, atrial ﬁbrillation.
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p = 0.578 and 43.7% vs. 44.5%; p = 0.934, respectively).
Interestingly, the ﬂuoroscopy time of the DPVPs group was
shorter than that of the non-DPVPs group (29.0  11.7 min vs.
31.5  12.6 min, p = 0.033). However, the total procedure time did
not signiﬁcantly differ between the two groups (4.80  1.16 h vs.
4.90  1.17 h, p = 0.372).
Follow-up results after the initial procedure
A total of nine patients (DPVPs group, six; non-DPVPs group,
three; p = 0.504) died an average of 19.9  18.4 months after their
last ablation (none within 30 days of the procedure). Eight of these
patients had undergone a single ablation, and one had had repeat
ablations. Six were AF-free at the time of their deaths (these data were
excluded in the analysis of AF recurrence). The cause of death wasTable 3
Impact of DPVPs on pulmonary vein reconnection (PVR) and clinical outcomes.
Factors DPVPs group
N = 378
Non-DPVPs group
N = 301
p-value
Acute PVR, n (%) 125 (33.1) 54 (17.9) <0.001
Time of acute PVR, min 16.4  9.5 18.8  9.7 0.114
Intraoperative PVR, n (%) 168 (44.4) 85 (28.2) <0.001
Time of intraoperative
PVR, min
25.4  25.2 26.2  17.6 0.796
Patients undergoing repeat
procedures, n (%)
33 (8.9) 42 (14.1) 0.033
Chronic PVR at repeat
procedure, n (%)
27 (81.8) 35 (83.3) 0.863
Single-procedure
successa, n (%)
244 (65.6) 168 (56.4) 0.015
Multiple-procedure
success, n (%)
269 (72.3) 199 (66.8) 0.121
DPVPs, dissociated pulmonary vein potentials.
a For both single and multiple ablations, procedural success was deﬁned as the
absence of symptomatic atrial ﬁbrillation (AF) or AF recurrences lasting for less
than 30 s in patients not receiving antiarrhythmic drugs, after a blanking period
of 3 months.myocardial infarction in one patient, progressive heart failure in one
patient, sudden death in two patients, non-cardiac death in four
patients, and unknown in one patient.
After the ﬁrst procedure, 244 of the 372 patients (65.6%) in the
DPVPs group were free of AF recurrence and maintained normal
sinus rhythm without antiarrhythmic agents during a mean
follow-up period of 32.5  15.1 months. In contrast, freedom from
AF recurrence after a single procedure was achieved in 168 of the
298 patients (56.4%) in the non-DPVPs group (p = 0.015, Table 3),
during a mean follow-up period of 32.9  13.6 months (p = 0.778).
Repeat procedure and follow-up results
In all, 75 patients (11.0%; DPVPs group, 33; non-DPVPs group,
42; p = 0.033; Table 3) underwent repeat ablation for recurrent
atrial arrhythmias, 15.3  11.2 months after the ﬁrst ablation
procedure. During the repeat procedure, the incidence of PVR was
similar in the DPVPs group (81.8%, 27/33) and the non-DPVPs group
(83.3%, 35/42, p = 0.863). The incidence of DPVPs at the repeat
procedure was 72.7% (24/33) in the DPVPs group and 40.5% (17/42) in
the non-DPVPs group (p = 0.005). After re-isolation, 70.0% (20/29) of
the left ipsilateral PVs with DPVPs in the ﬁrst ablation still presented
with DPVPs. 58.3% (14/24) of the right ipsilateral PVs with DPVPs in
the ﬁrst ablation still presented with DPVPs.
After the last procedure (1.09  0.28 times), 269 of the
372 patients (72.3%) in the DPVPs group were free of AF recurrence
and maintained normal sinus rhythm without antiarrhythmic
agents, during a follow-up period of 31.4  15.2 months. Freedom
from AF recurrence after multiple procedures (1.14  0.36 times;
p < 0.001) was achieved in 199 of the 298 patients (66.8%) in the non-
DPVPs group (p = 0.121, Table 3), during a follow-up period of
30.4  14.1 months (p = 0.413).
Furthermore, the success rate after the ﬁrst procedure and after
the last procedure was also similar in DPVPs present with
ﬁbrillatory activities and with ectopic rhythm (61.3% vs. 66.0%;
p = 0.598 and 74.2% vs. 72.1%; p = 0.807, respectively). The detailed
outcome data adjusted by AF type are manifested in the
supplement Table S1 and Table S2.
Discussion
According to the literature, DPVPs within the PVs have been
accepted as a sign of electrical disconnection from the LA during PV
isolation [5,6]. Such DPVPs are of several types, including single
ectopic, sustained PV rhythm, and PV ﬁbrillation [6,13]. The
incidence and characteristics of these DPVPs, most of which
were slow and repetitive, have been extensively studied
[5–7,10,11,13,14]. In our study, these DPVPs were deﬁned as
sharp and high-frequency potentials that were not associated with
far-ﬁeld atrial potentials or catheter manipulation. The incidence
of DPVPs in the PVs reportedly varies with the operation strategy,
from 9% following segmental isolation to 40% following antral
isolation [5–7]. Differences in deﬁnition, study population and
ablation approaches might account for these variations [14]. In our
large sample population, DPVPs were observed after circumferen-
tial PV isolation in 42.6% ipsilateral PVs and in 55.7% patients,
which were similar to the results of most other researches.
P cells, transitional cells, and Purkinje cells have been detected
in human PVs [15]. Therefore, the PVs may have the property of
autorhythmicity and may generate action potentials (DPVPs).
Indeed, DPVPs have been commonly observed after the PVs were
disconnected from the LA. The underlying mechanism may be that
the electrical activities of the autorhythmic cells in the PVs were
probably suppressed by a more rapid sinus rhythm. Consequently,
the presence of DPVPs indicated that the target PV may be an
arrhythmogenic PV and was isolated from the LA.
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DPVPs. However, apart from the type of procedure, factors that
inﬂuence the occurrence DPVPs in the PVs are not known. In
contrast to previous studies, this study aimed to determine the
factors that inﬂuence DPVPs. We found that male gender
(OR: 1.894) and paroxysmal AF (OR: 1.715) were independently
associated with the presence of DPVPs.
Focal ﬁring in the PVs is known to trigger AF or act as a rapid
driver to maintain AF [4]. The important role of PVs in paroxysmal
AF has been proved by considerable evidence [16,17]. In the case of
non-paroxysmal AF, however, several other mechanisms may
maintain the AF [18]. Furthermore, compared to paroxysmal AF,
persistent and long-standing persistent AF may result in more
extensive remodeling of the LA and PVs [4]. We presumed that
remodeling of the PVs and atria, including ﬁbrosis, may attenuate
or block the electrical activities of autorhythmic cells in the PVs.
Therefore, we considered that after PV isolation, DPVPs would
not appear as frequently in non-paroxysmal AF patients as in
paroxysmal AF patients.
Ongoing electrical and structural remodeling of the atria due to
aging, inﬂammation, and other comorbidities such as diabetes,
may lead to progressive atrial electrical instability [4]. Interesting-
ly, older age (p < 0.001), more comorbidities (p = 0.002; especially
RHD and diabetes mellitus) and a higher prevalence of cardiac
surgery history (p = 0.002) were found in the female patients in our
study (Table 2). Therefore, remodeling of the atrium and PVs may
have been more extensive or severe in the female patients. This
remodeling may account for the lower incidence of DPVPs in the
female patients, despite the higher incidence of paroxysmal AF
(p = 0.004).
The clinical implications of DPVPs during circumferential PV
isolation remain controversial [10,17,19]. In a study of 85 patients,
the occurrence of dissociated PV rhythm after PV isolation
was closely related to the acute PVR at 30 min after isolation
[10]. Interestingly, this ﬁnding was substantiated in our large
sample population. The incidence of acute and intraoperative PVR
was higher in the DPVPs group than in the non-DPVPs group (acute
PVR: 33.1% vs. 17.9%; p < 0.001; intraoperative PVR: 44.4% vs.
28.2%; p < 0.001). Considering that electrical activities are
expected to be more frequent if the isolated muscular sleeve is
large [14], PVs that show DPVPs may have a more circumferential
and thicker muscular sleeve, which may be difﬁcult to isolate and
may facilitate re-conduction. Therefore, the occurrence of DPVPs
after PV isolation was related to the incidence of acute and
intraoperative PVR. However, the presence of DPVPs in the initial
procedure did not affect the incidence of chronic PVR. This can be
explained by the ﬁnding that most PVs are found to be reconnected
with the LA during repeat procedures [20]. Therefore, the rate
of chronic PVR did not signiﬁcantly differ with the incidence of
DPVPs, as illustrated by our data (81.8% in the DPVPs group vs.
83.3% in the non-DPVPs group, p = 0.863).
In a study of 89 patients, the presence of DPVPs did not predict
recurrent AF following PV isolation (24% vs. 36%; p = 0.30)
[19]. However, another study of 196 patients reported that
dissociated PV electrical activities might identify a subgroup of
patients with relatively higher initial procedural success after
circumferential PV antrum ablation (p = 0.023) [17]. In our study,
the occurrence of DPVPs resulted in a better outcome after the ﬁrst
procedure (65.6% vs. 56.4% in the non-DPVPs group, p = 0.015) but
had no impact on the outcome after multiple procedures. The
above results were further supported in the subgroup of patients
with paroxysmal AF in our study. The different outcomes of the
DPVPs and non-DPVPs groups after the ﬁrst procedure may be
explained by the following: (i) DPVPs appeared more frequently in
those PVs without extensive or serious remodeling; therefore,
a smaller arrhythmogenic substrate was encountered in patientswith DPVPs. (ii) Patients without DPVPs might require additional
ablation for non-PV foci. (iii) Since acute and intraoperative PVR
was frequent in the DPVPs group, reinforcement ablation was
performed to completely re-isolate the target PVs, and this may
account for the higher success rate after the ﬁrst procedure.
(iv) More patients in the non-DPVPs group underwent repeat
procedures (partly due to more patients with non-paroxysmal AF
being present), which may have improved the clinical outcomes
after multiple procedures.
In conclusion, male gender and paroxysmal AF independently
inﬂuenced the occurrence of DPVPs in patients who underwent
circumferential PV isolation. DPVPs had a signiﬁcant impact on
acute and intraoperative PVR. The outcomes of the ﬁrst ablation
procedure were better in patients with DPVPs than in the non-
DPVPs patients.
Study limitations
In this study, due to economic reasons, a single Lasso catheter
was used for each patient, and it was placed within one of the
ipsilateral PVs. Therefore, the incidence of DPVPs may have
been underestimated. The follow-up data were mainly based on
periodic outpatient visits and telephone interviews. Continuous
electrocardiographic monitoring was not systematically per-
formed, as it was difﬁcult to implant invasive, arrhythmia-
monitoring devices in every patient. Although 24-h ambulatory
monitoring is an effective method to identify frequent asymptom-
atic recurrences, some asymptomatic paroxysmal arrhythmia
recurrences may have been missed. Thus, the true clinical success
rate may have been overestimated. If the follow-up had included
7-day Holter monitoring or event recorders, the results might have
been more accurate.
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